To evaluate the efficacy of eranda kshar yog and phaltrikadi yog in the management of medoroga w.r.t dyslipidemia
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2023/05/052340
- Lead Sponsor
- Ayurvedic and Unani Tibia College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a) Patients between the age group of 18-60 years of either sex.
b) Willing and able to participate in the study for 90 days.
c) Patients having Serum Cholesterol 201-400mg/dl, Serum Triglycerides 151- 400 mg/dI LDL Cholesterol 131-250 mg/dl, HDL
Details Cholesterol <40mg/dI.
d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%)
1) Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure ,Stroke or severe Arrhythmia, Unstable angina in the last six months.
2) Patients on prolonged ( >6weeks) medication with corticosteroids, antidepressants, anti cholinergics, immunosuppressant
3) Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents.
4)Patients with uncontrolled diabetes mellitus and HbA1C >7%
5) Patients with evidence of malignancy.
6)Hypersensitivity to any of the trial drugs or their ingredients.
7)Patients who have completed participation in any other clinical trial drugs or their ingredients in one month
8)Patients who have received any cholesterol lowering
medication (allopathic drug) within last two weeks.
9)Pregnancy and Lactating mother.
.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method